Awards celebrate scientists making a difference through scientific mentorship, humanitarian service, environmental stewardship and artistic/creative spirit IPSWICH, MA – New England Biolabs (NEB®) today announced an invitation for scientists to submit entries for the 2026 Passion in Science Awards, recognizing those within the scientific community working to make a difference in the areas of scientific mentorship, humanitarian […]

OBERKOCHEN, Germany — Revolune, a new life science company focused on enabling clearer insights from complex biological systems, today announced its official launch. The company is dedicated to advancing spatial biology through streamlined multiplex immunofluorescence (mIF) reagents designed to deliver reliable, efficient, and scalable tissue analysis workflows for translational and biopharma research. Modern biomedical research […]

The Content Innovation Engine brings together Akoya’s spatial biology platform and Quanterix’s immunoassay infrastructure to systematically unlock cancer biology and accelerate the path toward clinical application BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX) today announced plans to debut its Content Innovation Engine at the American Association for Cancer Research (AACR) Annual Meeting 2026. Built on the integration […]

ArgusEye AB today announce the appointment of Sofia Håkansson Buch as its new Chief Executive Officer (CEO), marking an important step in the company’s next phase of growth. With a strong background in biopharma, Sofia will lead the company’s continued growth and commercialization of its real-time bioprocess monitoring platform. Sofia brings extensive experience from the […]

New Offering Integrates DOPPL’s Patient-Derived Intestinal Organoid Technology with InSphero’s Proven Standardized Screening Model Schlieren, Switzerland – InSphero AG, the global leader in 3D cell-based assays and organ-on-chip systems, today announced the commercial launch of the 3D InSight™ Drug-Induced Gastrointestinal Toxicity (DIGIT) platform, a standardized, high-throughput screening solution for early assessment of gastrointestinal liabilities in drug discovery. […]

Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia ™Platform ·       Proceeds will help enhance workflows and expand single-cell functional assay portfolio ·       Brad Crutchfield joins as advisor to support early access growth and  global launch CAMBRIDGE, England – Lightcast, a pioneering life science tools company focused on functional single-cell analysis, today announced […]

North Brunswick, NJ – Distek, Inc., a leading provider of pharmaceutical and bioprocessing instrumentation, announced an exclusive manufacturers’ representative agreement with Optimal Biotech Group, LLC to support its BIOne benchtop bioreactor solutions across California, Oregon, and Washington. Through this agreement, Optimal Biotech Group will represent Distek’s BIOne portfolio, including the BIOne 250 and BIOne 1250 Bioreactor […]

Rapid preselection of high-producing clones from candidate pools, saving resources Monoclonality verification with automated documentation for full traceability Up to 100 percent transfer efficiency and viability to protect top clones for downstream expansion  Göttingen, Germany — Sartorius announces the launch of the CellCelector CLD, an automated imaging and cell isolation platform designed to simplify and accelerate […]

Partnership Delivers RoosterBio’s Research-Grade and CliniControl™ cGMP Media Platforms to China’s Leading Cell and Gene Therapy Developers; MineBio Holds Import Approval for Immediate Order Fulfillment FREDERICK, MD. — RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered bioprocess media, and advanced therapy manufacturing solutions for hMSCs and exosomes, today announced an […]

CAMBRIDGE, Mass. and SAN FRANCISCO, Calif. – Kytopen Corp., a leader in non-viral, continuous flow cellular engineering, today announced a Series B financing led by Telegraph Hill Partners, with participation from existing investors. The funding will accelerate Kytopen’s global commercial expansion and drive further adoption of its Flowfect® technology platform across the U.S. and Europe. […]